Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...
CNS Stimulants: Psychedelic Agents01:22

CNS Stimulants: Psychedelic Agents

Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chronic pain and stress: Transdiagnostic meta-analytic evidence of convergent network signature with PTSD.

Progress in neuro-psychopharmacology & biological psychiatry·2026
Same author

Modulation of emotion regulation deficits in patients with heroin use disorder by intermittent Theta-burst transcranial magnetic stimulation.

Progress in neuro-psychopharmacology & biological psychiatry·2026
Same author

Top-down rather than bottom-up attention processing mediates the pathway from childhood trauma exposure to depression in adolescents.

Journal of psychiatric research·2026
Same author

How Standardized Is Transcranial Magnetic Stimulation Treatment for Depression? Large-Cohort Modeling Reveals Systematic Dosimetric Variability.

Psychotherapy and psychosomatics·2026
Same author

Disgust Propensity, Not Disgust Sensitivity, Shapes the Reactivity of a Subjective Disgust Circuit in Humans.

Human brain mapping·2026
Same author

Animal models relevant to digital technology-based disorders.

Journal of behavioral addictions·2026
Same journal

Longitudinal association of switching to dual cigarette and e-cigarette use vs. continued exclusive cigarette smoking with tobacco-specific nitrosamine and nicotine intake.

Addiction (Abingdon, England)·2026
Same journal

Novel product, familiar challenges: Navigating uncertainty in oral nicotine pouch regulation.

Addiction (Abingdon, England)·2026
Same journal

Craving and personal functioning as mediators of extended-release buprenorphine efficacy: A four-way decomposition analysis from a randomised trial.

Addiction (Abingdon, England)·2026
Same journal

Alcohol consumption and the risks of morbidity and mortality across 39 diseases and conditions: A population-based cohort study in Korea.

Addiction (Abingdon, England)·2026
Same journal

A cross-sectional and prospective examination of alcohol use and misuse among adult twin and sibling pairs discordant for neighborhood socio-economic disadvantage.

Addiction (Abingdon, England)·2026
Same journal

The Cannabis Research Image Database (CRESIDA): A standardized and validated image set for studying cannabis cue reactivity.

Addiction (Abingdon, England)·2026
See all related articles

Related Experiment Video

Updated: May 20, 2026

Simultaneous Monitoring of Wireless Electrophysiology and Memory Behavioral Test as a Tool to Study Hippocampal Neurogenesis
07:25

Simultaneous Monitoring of Wireless Electrophysiology and Memory Behavioral Test as a Tool to Study Hippocampal Neurogenesis

Published on: August 20, 2020

A prospective study of learning, memory, and executive function in new MDMA users.

Daniel Wagner1, Benjamin Becker, Philip Koester

  • 1Department of Psychiatry and Psychotherapy, University of Cologne, Germany.

Addiction (Abingdon, England)
|July 27, 2012
PubMed
Summary
This summary is machine-generated.

New 3,4-methylenedioxymeth-amphetamine (MDMA) users showed impaired visual learning and memory. This suggests MDMA use may cause hippocampal dysfunction, impacting cognitive performance in new users.

More Related Videos

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
07:02

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development

Published on: February 11, 2019

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

Related Experiment Videos

Last Updated: May 20, 2026

Simultaneous Monitoring of Wireless Electrophysiology and Memory Behavioral Test as a Tool to Study Hippocampal Neurogenesis
07:25

Simultaneous Monitoring of Wireless Electrophysiology and Memory Behavioral Test as a Tool to Study Hippocampal Neurogenesis

Published on: August 20, 2020

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
07:02

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development

Published on: February 11, 2019

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

Area of Science:

  • Neuroscience
  • Psychopharmacology
  • Cognitive Psychology

Background:

  • Cognitive deficits in 3,4-methylenedioxymeth-amphetamine (MDMA) users are not well understood.
  • Previous studies lacked methodological rigor to establish causality.
  • Confounding factors may obscure the true effects of MDMA on cognition.

Purpose of the Study:

  • To investigate the relationship between the onset of MDMA use and subsequent cognitive function.
  • To address methodological limitations of prior research on MDMA and cognition.
  • To assess cognitive performance changes in new MDMA users over a 12-month period.

Main Methods:

  • Prospective cohort study design with 109 participants followed for 12 months.
  • Neuropsychological testing battery assessing learning, memory, and executive functions.
  • Multivariate analyses of variance comparing MDMA users (n=23) with controls (n=43) while controlling for confounders.

Main Results:

  • No significant differences in potential confounding variables between groups.
  • MDMA users exhibited significant impairments in immediate and delayed recall of visual paired associates learning.
  • No significant cognitive differences were observed in other tested domains.

Conclusions:

  • MDMA use appears to negatively impact visual paired associates learning in new users.
  • Findings suggest potential serotonergic dysfunction in hippocampal regions secondary to MDMA exposure.
  • This study provides evidence for MDMA-induced cognitive changes in early-stage users.